Clinical Study
Xyloglucan for the Treatment of Acute Gastroenteritis in Children: Results of a Randomized, Controlled, Clinical Trial
Table 1
Baseline demographic and clinical characteristics of children.
| | Statistical variable | Xyloglucan + ORS () | ORS () | Total () |
| Gender (girls) | (%) | 9 (50.00) | 12 (66.67) | 21 (58.33) | Age (years) | Mean (SD) | 4.72 (4.33) | 3.94 (3.26) | 4.33 (3.80) | Age ranges | (%) | | | | ≤1 year | | 3 (16.67) | 2 (11.11) | 5 (13.88) | 1–5 years | | 7 (38.89) | 10 (55.56) | 17 (47.22) | 5–10 years | | 4 (22.22) | 5 (27.78) | 9 (25.00) | >10 years | | 4 (22.22) | 1 (5.56) | 5 (13.88) | Hydration status | (%) | | | | Normal | | 11 (61.11) | 13 (72.22) | 24 (66.66) | Mild dehydration | | 7 (38.89) | 5 (27.78) | 12 (33.33) | Body temperature | | | | | ≤37°C | | 9 (50.00) | 7 (38.89) | 16 (44.44) | 37-38°C | | 5 (27.78) | 6 (33.33) | 11 (30.55) | >38°C | | 4 (22.22) | 5 (27.78) | 9 (25.00) |
|
|
ORS: oral rehydration solution; SD: standard deviation.
|